| Date | Title | Description |
| 03.02.2025 | Apollo Heart Valve Clinic at Indraprastha Apollo Hospital (New Delhi) Combines Innovation and Expertise for Better Patient Outcomes | New Delhi, Delhi, India
Indraprastha Apollo Hospitals proudly announces the launch of its Heart Valve Clinic, a dedicated facility designed to provide world-class care for heart valve disorders. This advanced clinic combines cutting-edge te... |
| 02.01.2025 | Breaking Barriers and Building Futures: HR Asia's Best Companies to Work for in 2024 Malaysia Announced | KUALA LUMPUR, Malaysia, Jan. 2, 2025 /PRNewswire/ -- HR Asia, the leading publication in the human resources industry, announces the winners of its prestigious HR Asia Best Companies to Work for in Asia 2024. This year, a total of 66 outsta... |
| 21.12.2024 | Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards | Commercial validation in Europe parallels ongoing RESPONDER-HF clinical trial
TEWKSBURY, Mass., Dec. 21, 2024 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure, announced today that it ... |
| 20.11.2024 | Сердце требует технологий | - |
| 08.11.2024 | CIIE: Edwards Lifesciences to Debut More Heart Valve Solutions in China, Local GM Says | (Yicai) Nov. 8 -- Edwards Lifesciences will accelerate the introduction of new cardiovascular products into China after the approval of Mitris Resilia mitral valve replacement, the general manager of the American heart valve manufacturer sa... |
| 25.10.2024 | Corvia Medical Announces Three-Year Clinical Trial Results Confirming Significant and Durable Benefits of the Corvia Atrial Shunt in Heart Failure Patients | 44% reduction in total heart failure event rate and ongoing improvements in quality of life in responder group patients implanted with shunt
TEWKSBURY, Mass., Oct. 25, 2024 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transfo... |
| 06.09.2024 | Weekly Recap: 10 Health Press Releases You Might Have Missed | A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including a new COVID-19 vaccine, Prostate Cancer Awareness Month news and Walk to End Alzheimer's.
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- With thousand... |
| 04.09.2024 |
Edwards Lifesciences starts global layoffs | Edwards Lifesciences (NYSE: EW) + has initiated layoffs across the device developer’s global footprint after completing the $4.2 billion sale of its Critical Care business to Becton, Dickinson and Co.
About 3% of the company’s workforce wil... |
| 29.08.2024 | The Surge of Cardiac Surgery: A Market in Motion | The global cardiac surgery market is on the rise. It’s a lifeline in a world grappling with cardiovascular diseases (CVDs). These diseases are silent killers, claiming over 17 million lives each year. As technology advances, the market is p... |
| 29.08.2024 | Peijia Medical's Strong Growth in 2024: A Deep Dive into Interim Results | Peijia Medical, a prominent player in China's medical device market, has unveiled its interim results for the first half of 2024. The numbers tell a compelling story of growth, resilience, and strategic execution. With a sharp focus on tran... |
| 28.08.2024 | Cardiac Surgery Market to Exceed $24B Due to Global Shift Towards Minimally Invasive Surgeries (TAVI/TAVR and TMVr) | iData Research | VANCOUVER, BC, Aug. 28, 2024 /PRNewswire/ - In a world, where cardiovascular diseases (CVDs) remain a leading cause of death, the global cardiac surgery market has emerged as a cornerstone of life-saving interventions, driven by innovations... |
| 26.08.2024 | Peijia Medical Announces 2024 Interim Results | HONG KONG, Aug. 26, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the six month... |
| 26.08.2024 | Peijia Medical Announces 2024 Interim Results | HONG KONG, Aug. 26, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the six month... |
| 19.08.2024 | Genesis MedTech Announces the Sale of JC Medical, Inc to Edwards Lifesciences | SINGAPORE, Aug. 19, 2024 /PRNewswire/ -- Genesis MedTech has sold JC Medical, Inc. to Edwards Lifesciences, including the intellectual property and commercial rights of its J-Valve® System, a transcatheter aortic valve replacement for the t... |
| 25.07.2024 | Peijia Medical's Licensing Partner, JenaValve Technology, Inc., is Expected to be Acquired by Edwards Lifesciences | Peijia to maintain exclusive rights in Greater China to commercialize JenaValve's Trilogy Transcatheter Heart Valve (THV) System
SUZHOU, China, July 25, 2024 /PRNewswire/ -- Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese dome... |
| 15.07.2024 | Edwards Lifesciences to Acquire Innovalve | Edward Lifesciences (NYSE: EW), an Irvine, CA-based global leader in patient-focused innovations for structural heart disease and critical care monitoring, acquired Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve repla... |
| 10.07.2024 | В Кузнецке появится современный центр сердечно-сосудистой хирургии | - |
| 07.07.2024 | Инвестиционные идеи: список 17 акций для инвестирования от Deutsche Bank | В обновленный список попали производители обуви Birkenstock, сервис такси Uber, разработчик софта Adobe и промышленная корпорация Emerson Electric.
Deutsche Bank обновляет свой список ежеквартально. Сейчас в него входят 36 компаний из пяти ... |
| 03.06.2024 | BD Acquires Edwards Lifesciences’ Critical Care Unit for $4.2B to Strengthen Smart Connected Care Portfolio | What You Should Know:
– Becton, Dickinson and Company (BDX: NYSE), a global leader in medical technology, announced today a definitive agreement to acquire Edwards Lifesciences’ (EW: NYSE) Critical Care product group for $4.2 billion in cas... |
| 25.04.2024 |
Edwards Lifesciences beats the Street in Q1 and increases sales outlook | Edwards Lifesciences (NYSE: EW) + reported first-quarter results that exceeded Wall Street expectations after market close today.
The maker of catheter-delivered heart implants — including transcatheter aortic valve replacement (TAVR) syste... |
| 01.04.2024 | Beckman Foundation Hosts Irvine Tech Week Forum Exploring Future of Life Sciences Tech | Beckman Foundation’s Life Sciences Tech & Trends Forum will provide attendees with important information about the state of the industry as well as insight about what its future holds.
Orange County Institution Invites Panel of Industry... |
| 04.03.2024 | Structural Heart Devices Market Surges as Aging Population Spurs Cardiovascular Health Concerns | A structural heart disease is a non-coronary defect of the heart, thus not affecting the blood vessels in the heart.
PORTLAND, OREGON, UNITED STATES, March 4, 2024 /EINPresswire.com/ -- According to a new report published by Allied Market R... |
| 25.10.2023 |
Edwards Lifesciences says TAVR drove 12% sales growth in Q3 | Edwards Lifesciences (NYSE: EW) + this evening reported third-quarter results that met Wall Street expectations, with solid sales growth keeping it on track to boost revenue by up to 13% this year.
Perhaps investors initially expected more ... |
| 02.03.2023 | Practice makes perfect as Zurich's Simulands receives €10 million | Simulands, a Swiss creator of simulation devices for cardiovascular medicine, recently obtained €10 million to give cardiologists sound training that's appropriate for the mission-critical nature of their field.
The funding is being supplie... |
| 08.12.2022 | Healthcare Hires of Note | 1upHealth, a FHIR data platform and health data cloud, announced that Pieter De Leenheer has joined the executive team as the chief technology officer. De Leenheer will oversee the company’s technology strategy and capabilities including pl... |
| 08.12.2022 |
Edwards Lifesciences CEO to step down next year | Mike Mussallem [Image courtesy of Edwards Lifesciences]Edwards Lifesciences (NYSE:EW) announced today that Michael A. Mussallem, chair and CEO, intends to retire next year.
Mussallem, 70, informed the board of his decision to retire in conn... |
| 26.04.2022 | Edwards Lifesciences shares fall on Street-beating Q1 results | Edwards Lifesciences (NYSE: EW) posted first-quarter results today that beat the consensus forecast on Wall Street.
It also reaffirmed its outlook for the rest of the year, with CEO Michael Mussallem saying, “We are hopeful the worst of the... |
| 27.01.2022 | EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS | IRVINE, Calif., Jan. 26, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2021.
Fourth Quarter Highlights and Outlook
2021 sales grew 19 percent, or 18 percent on an un... |
| 28.10.2021 | Edwards Lifesciences reports mixed Q3 financial results | Edwards Lifesciences (NYSE: EW) reported third-quarter financial results that exceeded Wall Street’s expectations on profits but narrowly missed on sales.
The Irvine, California–based cardio device company yesterday evening reported earning... |
| 02.08.2021 | Edwards Lifesciences : initiates $100 million social impact investment fund to advance racial equity | Edwards Lifesciences initiates $100 million social impact investment fund to advance racial equity
IRVINE, Calif., Aug. 2, 2021 - Edwards Lifesciences Corporation (NYSE: EW) today announced it has established a Social Impact Investment Fund... |
| 29.07.2021 | Edwards Lifesciences : Reports Second Quarter Results | IRVINE, Calif., July 29, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2021.
Second Quarter Highlights and 2021 Outlook
Sales rebounded and grew 49 percent to $1.4 billi... |
| 29.07.2021 | Edwards Lifesciences Reports Second Quarter Results | |
| 22.07.2021 | Study Data Presented at TVT on the Economics of Minimalist TAVR, PARTNER 3 Bicuspid TAVR | |
| 22.07.2021 | Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021 | |
| 01.06.2021 | Edwards Receives Clearance For Hypotension Prediction Index Software For Noninvasive Acumen IQ Cuff | |
| 01.06.2021 | EDWARDS LIFESCIENCES CORPORATION
Edwards Lifesciences : Receives Clearance For Hypotension Prediction Index Software For Noninvasive Acumen IQ Cuff | IRVINE, Calif., June 1, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that Acumen Hypotension Prediction Index (HPI) software with the Acumen IQ finger cuff has received U.S. Food and Drug Administration clearance. Th... |
| 05.05.2021 | Edwards Announces Updates From Annual Meeting | |
| 27.04.2021 | Buchanan & Edwards Lands $80M U.S. Department of Labor Contract to Support Job Corps Data Center IT Facilities | We are looking forward to providing the OJC with the support and dedication that BE’s Cloud & Infrastructure Practice has become known for.
WASHINGTON (PRWEB) April 27, 2021
Buchanan & Edwards Inc., an award-winning and fast-growing... |
| 20.04.2021 | EDWARDS LIFESCIENCES CORPORATION
Edwards Lifesciences : Reports First Quarter Results | IRVINE, Calif., April 20, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2021.
First Quarter Highlights and 2021 Outlook
Sales grew 8 percent to $1.2 billion; underlying... |
| 20.04.2021 | Edwards Lifesciences Reports First Quarter Results | |
| 13.04.2021 | Edwards Lifesciences To Host Earnings Conference Call On April 20, 2021 | |
| 27.01.2021 | Edwards Lifesciences Reports Fourth Quarter Results | |
| 13.01.2021 | Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021 | |
| 10.12.2020 | Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference | |
| 21.10.2020 | Edwards Lifesciences Reports Third Quarter Results | |
| 07.10.2020 | Edwards Lifesciences To Host Earnings Conference Call On October 21, 2020 | |
| 19.03.2019 | The astounding 19-year journey to a sea change for heart patients | When she was 9, in 1949, Brunhilde “Brunie” Seffens contracted scarlet fever. In postwar Germany, where she lived, antibiotics were not broadly used. Doctors told her she would probably develop heart problems when she was older.
Seffens gre... |
| 11.03.2019 | Edwards Lifesciences announces exclusive right to acquire Corvia Medical, Inc. | IRVINE, Calif., — Edwards Lifesciences Corporation EW, -0.99% the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced two strategic transactions involving companies with st... |
| 31.10.2017 | Health2047 spins out healthcare data sharing business | The move follows the addition of Celgene as a collaboration partner last month. The pharma company was brought on board by Health 2047 to help build the health data transfer business. Doug Given, Health2047 CEO, explained at the time that t... |
| 28.11.2016 | Edwards makes another big acquisition in the transcatheter mitral valve space, this time for $690M | When the transaction closes in early 2017, Edwards will fork up $340 million in cash and stock with the promise to make milestone payments of an additional $350 million over the next decade. Those “pre-specified” milestone payments were not... |
| 18.08.2016 | Aortic stenosis patients with moderate risk to open-heart surgery can now choose TAVR instead | One such company is Edwards Lifesciences that announced Thursday that the Food and Drug Administration has expanded the label indication for its Sapien 3 TAVR valve to include patients who have intermediate risk for open-heart procedures.
W... |
| 13.07.2015 | Morning Read: As telemedicine grows, so do tensions, White House hosts Conference on Aging | LIFE SCIENCE
Wistar Institute in Philadelphia has partnered with biotechnolgy manufacturer Rockland Immunochemicals to develop Wistar’s biologics and biomarkers. — Philadelphia Business Journal
Edwards Lifesciences has acquired transcathete... |
| 12.12.2014 | CardioKinetix signs option-to-buy agreement with Edwards Lifesciences; raises $50M | Medtech funding for the week of December 8, 2014 | CardioKinetix raises $50m, inks buyout deal with Edwards Lifesciences December 8, 2014 by Val Kennedy
CardioKinetix said it signed an exclusive option-to-buy agreement with Edwards Lifesciences in connection with a $50 million financing rou... |
| 23.10.2014 | Edwards Lifesciences posts double-digit Q3 sales, earnings increases | Edwards Lifesciences (NYSE:EW) increased its 3rd-quarter sales and earnings by more than 20% each and raised its outlook for the rest of the year, sending share prices up sharply in after-hours trading today
Irvine, Calif.-based Edwards rep... |
| 17.06.2014 | Press Release: Edwards lifesciences launching Sapien XT valve in the U.S. | IRVINE, Calif. – Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has received United States Food and Drug Administration (FDA) approval for it... |
| 11.02.2014 | Q & A: Collaboration between physicians and medical technology companies crucial | by Chris White and Diane Biagianti
Partners for Healthy Dialogues partner Christopher White (general counsel, AdvaMed) recently sat down with Diane Biagianti, vice president, chief responsibility officer, Edwards Lifesciences, to talk about... |
| 05.02.2014 | Edwards lands E.U. approval for transcatheter mitral or aortic valve-in-valve | Medtech titan Edwards Lifesciences (NYSE:EW) today announced that it received CE Mark approval from European regulators to market its next-generation Sapien XT transcatheter valve system for either mitral or aortic valve-in-valve implantati... |
| 04.02.2014 | Edwards Lifesciences beats Q4 earnings call, says mitral valve program delayed | Edwards Lifesciences (NYSE:EW) topped the consensus forecast for its 4th-quarter earnings per share, but a delay in its replacement mitral valve program and lower-than-expected earnings guidance for 2014 sent the medical device company’s st... |
| 05.12.2013 | Edwards Lifesciences names Scott Ullem its new CFO | Medtech titan Edwards Lifesciences (NYSE:EW) today named Scott Ullem its new chief financial officer, replacing retiring CFO Thomas Abate. Ullem will take on the role at the start of 2014.
Abate in May announced his intention to step down, ... |
| 31.10.2013 | Edwards Lifesciences gets in on $3M Series A tranche for Middle Peak Medical | Middle Peak Medical said it added $3 million from Edwards Lifesciences (NYSE:EW) and other investors to its Series A round, taking the total raise to $11 million.
Palo Alto, Calif.- and Munich-based Middle Peak is developing technology to t... |
| 30.10.2013 | FDA device approval imminent? Impressive CoreValve data allows Medtronic to skip advisory panel | The FDA has determined it will conduct separate reviews for the Trial’s Extreme Risk and High Risk studies. Upon reviewing the CoreValve Trial’s results for extreme risk patients, the FDA has determined it has sufficient information to eval... |
| 29.10.2013 | Edwards Lifesciences jumps in mitral valve tech race with startup investment | Follow MedCity News on Facebook and Twitter for more updates.
Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underser... |
| 24.10.2013 | What Starbucks, #PSL and Teavana can teach top medical device companies | Many of the top medical device companies are still only selling coffee. But there are a few things these industry giants can learn to sell an experience like Starbucks. (Hint: The patients are consumers now.)
1. Create a sense of community.... |
| 07.10.2013 | Medtronic’s busy day at the U.S. Supreme Court | This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has never been m... |
| 26.08.2013 | German ban on Medtronic TAVI begins today, Edwards makes room for ‘compassionate cases’ | Starting today, medical device giant Medtronic (NYSE:MDT) is banned from selling its CoreValve and CoreValve Evolut transcatheter aortic valve implantation systems in Germany, thanks to a court ruling in favor of rival device maker Edwards ... |
| 26.07.2013 | EW performs slightly better than expected in Q2, looks forward to SAPIEN, mitral developments | “The difference between Q2 and going forward, Q3 and Q4, is we lose some of the benefit on the year-over-year comparison due to FX,” CFO Thomas Abate said. In the first half of the year, the company had about $150 million from FX to “help.”... |
| 30.05.2013 | Investors shrug off FDA warning letter for Edwards | Investors seemed unfazed by news of a warning letter from the FDA for Edwards Lifesciences (NYSE:EW) over a Utah cardiac surgery systems plant.
That’s because CSS products amounted to less than $10 million in sales last year, about 2% of th... |
| 09.04.2013 | Automated suture system for minimally invasive surgery raises $5 million | EndoEvolution’s automated sutures are for bariatric, colorectal and general surgery along with gynecology, according to a press release. Last year, Edwards Lifesciences (NYSE:EW) licensed EndoEvolution’s automated suturing device technology... |
| 20.12.2012 | I’ll Take ‘Orange County Technologies that Could Change Your Life’ for $200 | Facebook changed the way that you keep in touch with your former high school friends, but how significantly did it impact your day-to-day life? While Silicon Valley gets all of the attention, Orange County is churning out radical innovation... |
| 29.11.2012 | Edwards wins Chinese approval for Perimount mitral valve | Medical device giant Edwards Lifesciences (NYSE:EW) touted China State Food & Drug Administration approval for its Carpentier-Edwards Perimount replacement mitral heart valve, part of the Perimount suite of devices that Edwards says are... |
| 19.10.2012 | Edwards wins extended Sapien TAVI approval, sinks on disappointing Q3 | Edwards Lifesciences (NYSE:EW) won FDA approval to market its Sapien transcatheter aortic valve implantation system to lower-risk patients, despite concerns about limited patient data on the long-term side effects of the device.
The approva... |
| 10.10.2012 | Edwards Lifesciences closes $42M buyout of Dutch hemo monitoring company | Edwards Lifesciences (NYSE:EW) won some Wall Street love after it closed the books on a $42 million buyout of privately held Dutch hemodynamic monitoring technology company BMEYE B.V.
EW shares gained 3.7% today, trading at $87.69 as of abo... |
| 04.09.2012 | Fundraising: Startup developing less-invasive hemodynamic monitor raises $7 million | Solution/product: The Retia monitor is a cardiovascular signal processing device that is less invasive and based on technology licensed from Michigan State University and MIT. It is designed to monitor patients who go into shock. The produc... |
| 25.07.2012 | Fundraising: Percutaneous mitral valve repair company raises $14.8 million | Industry: Medical Devices
Products: Developing PerCu-Pro System that is an implanted device to percutaneously repair the mitral valve to prevent blood leaking into the left ventricle (also known as mitral valve regurgitation); the Dexterity... |
| 02.07.2012 | Edwards Intuity wins FDA nod for “rapid deploy” heart valve trial | Edwards Lifesciences (NYSE:EW) won an investigational device exemption from the FDA to begin a clinical trial of its Edwards Intuity heart valve.
The device maker’s Transform trial is the 1st of its kind in the U.S. for a rapid deployment s... |
| 10.05.2012 | Why a Medtronic executive wants rival Edwards Lifesciences to succeed | So it was surprising when Medtronic’s vice president of business development Chad Cornell admitted that he was rooting for Edwards.
“We need Edwards to succeed in transcatheter valve replacement,” Cornell told an audience gathered at the IB... |
| 29.03.2012 | What the TAVI trials’ stroke data means for Medtronic and Edwards | Wall Street took notice, but the good news needs to be parsed.
Dr. Axel Linke, who presented Medtronic’s CoreValve results at the ACC meeting, said that while he couldn’t say exactly what led to fewer strokes, the study could have benefited... |
| 16.02.2012 | Edwards lands CE Mark for Intuity valve | Regulatory Roundup | Edwards Lifesciences Corp. (NYSE:EW) landed CE Mark approval in the European Union for its Intuity valve system.
The Intuity valve, made of bovine pericardial tissue, is a minimally invasive option for patients in need of aortic valve repla... |
| 15.02.2012 | Shining the light | By Westby G. Fisher, MD, FACC
Doctors are under the Sunshine Act to disclose the dollars we receive from industry:
The Physician Payments Sunshine Act requires companies to begin recording any physician payments that are worth more than $10... |
| 09.08.2011 | Edwards lands four-year $500 million revolving credit facility | Funding Roundup | Edwards Lifesciences Corp. (NYSE:EW) landed a new four-year $500 million credit facility after canceling a prior one a couple months early.
The old facility was a five-year deal, also for $500 million, that was scheduled to mature September... |
| 25.07.2011 | The MassDevice Weekly Checkup: July 25, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 22.07.2011 | Shares of Edwards continue to slide despite positive FDA, earnings news | Shares of Edwards Lifesciences Corp. (NYSE:EW) continued to slide on Wall Street for the second straight day, despite positive earnings and a favorable FDA panel vote that should clear the way for the company to launch the Sapien transcathe... |
| 22.07.2011 | Edwards can’t seem to please The Street | Earnings Roundup | Shares of Edwards Lifesciences Corp. (NYSE:EW) continued to slide on Wall Street for the second straight day, despite positive earnings and a favorable FDA panel vote that should clear the way for the company to launch the Sapien transcathe... |
| 14.07.2011 | St. Jude’s Ilumien hybrid wins CE Mark | Regulatory Roundup | St. Jude Medical Inc. (NYSE:STJ) landed CE Mark approval in the European Union for what it bills as the first and only hybrid diagnostic imaging system to combine optical coherence tomography and fractional flow reserve technology into a si... |
| 25.04.2011 | The MassDevice Weekly Checkup: April 25, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 04.04.2011 | ACC 2011: Edwards’ Sapien valve beats open heart surgery on survival rates and cost | Edwards Lifesciences Inc. (NYSE:EW) is highlighting a pair of studies on its Sapien transcatheter aortic-valve implantation technology suggesting that the device is cheaper and more effective than traditional open heart surgery.
Results fro... |
| 14.03.2011 | Edwards Lifesciences buys Embrella Cardiovascular for $43 million | Edwards Lifesciences Inc. (NYSE:EW) scooped up Embrella Cardiovascular for a cool $43 million.
Wayne, Pa.-based Embrella makes embolic protection devices used in coronary procedures such as transcatheter valve replacements. Edwards official... |
| 02.03.2011 | Edwards Lifesciences gains on CE Mark for bigger aortic valve | Edwards Lifesciences Inc. (NYSE:EW) is looking to finish today’s session on a up note, with shares rising nearly 5 percent after European officials approved a third size of the company’s Sapien XT transcatheter aortic heart valve.
The CE Ma... |
| 22.02.2011 | FDA regulations will send medical device companies out of US, VC warns | LaViolette is no stranger to the device market or to the FDA’s Center for Devices & Radiological Health. He spent 15 years at the Natick, Mass.-based device giant, with stops as president of the cardiology and international groups. His ... |
| 22.02.2011 | Top device VC: Fix FDA or watch business go to Costa Rica | A Boston, Mass.-based venture capitalist and former Boston Scientific Corp. (NYSE:BSX) executive is adding his voice to the chorus of medical device stakeholders calling for an overhaul to the way the FDA regulates medical devices.
In a col... |
| 09.11.2010 | Feds subpoena Edwards Lifesciences over heart monitor | Edwards Lifesciences Corp. (NYSE:EW) revealed yesterday a U.S. Attorney’s Office for Central California subpoena for documents related to its 2006 heart monitor recall.
The Irvine, Calif.-based cardiac device maker said the court communicat... |
| 21.09.2010 | The MassDevice Weekly Checkup: September 21, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 08.06.2010 | The MassDevice Weekly Checkup: June 8, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 02.06.2010 | The MassDevice Weekly Checkup: June 1, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 02.04.2010 | Edwards wins $74 million judgment in patent war with Medtronic’s CoreValve | Edwards Lifesciences Inc. (NYSE:EW) won a major round in its patent war with Medtronic Inc. (NYSE:MDT) subsidiary CoreValve when a Delaware federal jury ruled that CoreValve willfully infringes an Edwards patent.
The jury in the U.S. Distri... |
| 05.02.2010 | Edwards Lifesciences posts double-digit Q4 sales and earnings increases | Edwards Lifesciences Corp. (NYSE:EW) posted fourth-quarter sales of $346.7 million for the three months ended Dec. 31, 2009, up 11.9 percent compared with $309.7 million during the same period last year. Net income rose 24.9 percent to $47.... |
| 08.10.2009 | Amsterdam-based BMEYE Completes €6M Series B Financing Round | BMEYE B.V., a provider cardiovascular monitoring systems, completed its 6m Series B financing round led by new investors Earlybird with participation from 360 Capital Partners, Life Sciences Partners and Techfund.
The funds will support the... |
| 24.09.2009 | Cleveland Clinic surgeon joins scientific board of vascular device company | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| - | EW performs slightly better than expected in Q2, looks forward to SAPIEN, mitral developments | Edwards LifeSciences Corp. reported a total revenue of $517 million for Q2, with 7.3 percent increased net sales, “driven by strong sales of transcatheter and surgical heart valves in both the U.S. and Europe,” CEO Michael Mussalem said. Co... |
| - | Medtronic’s busy day at the U.S. Supreme Court | The U.S. Supreme Court has decided to reject a Medtronic (MDT) appeal and leave the Edwards Lifesciences (EW) valve patent intact, which stands to lose Medtronic as much as $200 million, Bloomberg reports. The medical device company has rec... |
